usurpation

A cancer-focused biotech company has sued eight of America’s biggest traders, including Citadel Securities, Susquehanna and Virtu, alleging they deliberately depressed its stock price by placing sell orders they didn’t have not intend to perform. The lawsuit, filed Thursday by Northwest Biotherapeutics in federal court in New York, alleged that marketers “deliberately engaged in repeated …

Cancer drug company accuses U.S. market makers of stock usurpation Read More »